Gilead Sciences Buy Hold or Sell Recommendation

GILD -- USA Stock  

USD 71.46  0.39  0.55%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Gilead Sciences is 'Strong Hold'. Macroaxis provides Gilead Sciences buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Gilead Sciences positions. The advice algorithm takes into account all of Gilead Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Gilead Sciences buy-and-hold prospective. Please also check Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.

Time Horizon

Risk Tolerance

Symbol
Execute Advice

Gilead Sciences Current Recommendation

SellBuy
Strong Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Gilead Sciences has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0
Macroaxis provides unbiased buy or sell recommendations on Gilead Sciences that should be used to complement current analysts and expert consensus on Gilead Sciences. Our buy, hold, or sell suggestion engine determines the entity potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Gilead Sciences is not overpriced, please check out all Gilead Sciences fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Given that Gilead Sciences has Price to Earning of 27.03 times, we strongly advise you confirm Gilead Sciences market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Gilead Sciences Thematic Classifications

Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals

Returns Distribution Density

Mean Return0.20Value At Risk1.29
Potential Upside2.73Standard Deviation1.21
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Blackrock IncCommon Shares105.2 M7.9 B
Vanguard Group IncCommon Shares95.1 M7.2 B
State Street CorpCommon Shares53.9 M4.1 B
Capital Research Global InvestorsCommon Shares42.9 M3.2 B
Bank Of New York Mellon CorpCommon Shares27.7 M2.1 B
Fmr LlcCommon Shares24.7 M1.9 B
Parnassus InvestmentsCommon Shares19.7 M1.5 B

Gilead Sciences Greeks

α
Alpha over DOW
=0.00
β
Beta against DOW=0.00
σ
Overall volatility
=1.21
Ir
Information ratio =0.00

Gilead Sciences Volatility Alert

Gilead Sciences exhibits relatively low volatility with skewness of 1.14 and kurtosis of 0.9. However, we advice investors to further investigate Gilead Sciences to make sure all market statistics is disseminated and is consistent with investors' estimations about Gilead Sciences upside potential.
    
 Better Than Average     
    
 Worse Than Average Compare Gilead Sciences to competition

Gilead Sciences Fundamental Vs Peers

FundamentalsGilead SciencesPeer Average
Return On Equity16.76 % (15.17) %
Return On Asset13.00 % (15.64) %
Profit Margin14.03 % (5.50) %
Operating Margin57.29 % (10.91) %
Current Valuation95.69 B152.14 B
Shares Outstanding1.3 B1.43 B
Shares Owned by Insiders0.66 % 6.91 %
Shares Owned by Institutions80.54 % 18.37 %
Number of Shares Shorted18.14 M3.24 M
Price to Earning27.03 times40.69 times
Price to Book4.49 times14.44 times
Price to Sales3.74 times17.81 times
Revenue24.69 B9.85 B
Gross Profit21.74 B21.75 B
EBITDA14.15 B1.41 B
Net Income3.46 B517.71 M
Cash and Equivalents24.68 B3.89 B
Cash per Share18.98 times5.17 times
Total Debt29.05 B7.36 B
Debt to Equity140.60 % 0.72 %
Current Ratio2.84 times3.30 times
Book Value Per Share15.84 times13.64 times
Cash Flow from Operations9.75 B1.25 B
Short Ratio2.12 times2.09 times
Earnings Per Share2.63 times2.30 times
Price to Earnings To Growth1.86 times1.22 times
Number of Employees10 K10.67 K
Beta1.30.34
Market Capitalization92.41 B29.78 B
Total Asset1.29 B126.86 B
Retained Earnings18.15 B38.24 B
Working Capital1.08 B3.58 B
Current Asset1.18 B36.8 B
   Exercise or conversion by Kevin Young of 10000 shares of Gilead Sciences subject to Rule 16b-3 [view details]

Gilead Sciences Alerts

Trading Alerts and Improvement Suggestions
Gilead Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 81.0% of the company shares are owned by institutional investors
On June 14, 2018 Gilead Sciences paid $ 0.57 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Sale by William Lee of 4180 shares of Gilead Sciences

Did You Try This Idea?

Run Wholesale Thematic Idea Now
Wholesale
Wholesale Idea
Fama and French focus on testing asset pricing under different economic assumptions. Wholesale theme has 61 constituents.
View All  Next Launch Wholesale
Please also check Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.